Citation Impact
Citing Papers
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Rational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast Cancer
2004
Dose-related nephrotoxicity of carboplatin in children
1999
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
1995
High-Dose Cyclophosphamide, Carboplatin, and Etoposide with Autologous Stem Cell Rescue in Patients with Breast Cancer
1996
Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application
1996
Chemokines and leukocyte traffic
1998 StandoutNature
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Chemotherapy for small cell lung cancer
2003
Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors
1998
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.
1994
PET and [18F]-FDG in oncology: A clinical update
1996
Large quantity production with extreme convenience of human SDF‐1α and SDF‐1β by a Sendai virus vector
1998 StandoutNobel
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
1998
Mesenchymal stem cells in health and disease
2008 Standout
Escalating drug delivery in cancer chemotherapy: A review of concepts and practice —Part 2
1993
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Cancer of the Ovary
1993
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
1999
Vascular disorders of the liver # †
2008 Standout
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: Incidence, risk factors, and outcome
1999
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
1998 StandoutNature
Cellular processing of platinum anticancer drugs
2005 Standout
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
2004 Standout
[27] The signal sequence trap method
1999 StandoutNobel
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
1992
Bone Marrow Transplantation
1994
Microtubules as a target for anticancer drugs
2004 Standout
Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer
1997
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
2000
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
1998
A Review of Chemotherapy Trials for Malignant Mesothelioma
1998
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Cancer of the Ovary
2004 Standout
Minor Increases in Plasma Troponin I Predict Decreased Left Ventricular Ejection Fraction after High-Dose Chemotherapy
2003
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
2004 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Chemokines
1997 Standout
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Proliferating dendritic cell progenitors in human blood.
1994 StandoutNobel
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma
2001
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
2001 Standout
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
1991
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
1999
Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer
1996
Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis
2010
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
1998 StandoutNobel
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Prognostic Factors in Metastatic Melanoma: A Pooled Analysis of Eastern Cooperative Oncology Group Trials
2000
Pleural mesothelioma: combined modality treatments
2002
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
1994
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
1993
Peripheral blood stem cells reach new heights [editorial; comment]
1993
Metal–Organic Frameworks in Biomedicine
2011 Standout
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.
1998
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
2000 Standout
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
1994
The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood
1997
Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
2000
The verdict is not in yet. Analysis of the randomized trials of high-dose chemotherapy for breast cancer.
2003
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
1998 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
Plasma elevation of stromal cell–derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells
2001 StandoutNobel
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Cytokine-induced radiation protection and sensitization
1996
Works of M Hunt being referenced
An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma
1992
GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols
1991
Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer
1993
Neoadjuvant chemotherapy in marginally resectable stage III M0 non‐small cell lung cancer: Long‐term follow‐up in 41 patients
1989
Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
1990
Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study
1991
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.
1992
A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.
1990
Phase II Trial of Carboplatin in Patients with Metastatic Malignant Melanoma
1993
A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.
1991
Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer
1992